These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25674243)

  • 1. Transfer of human hepatocyte growth factor reduces inflammation and prevents pulmonary arterial remodeling in monocrotaline-induced.
    Chen J; Zhang H; Zhang R; Liu Z; Wang J; Xiao M; Ba M; Yao F; Liu J; Huang S; Zhong J
    Int J Clin Exp Pathol; 2014; 7(12):8763-9. PubMed ID: 25674243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatocyte growth factor intervention on rats with pulmonary hypertension and effect of endothelial cell membrane microparticles].
    Liu Z; Zhang R; Yang Y; Wang J; He Z; Chen J
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):433-6. PubMed ID: 25200043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early treatment with hepatocyte growth factor improves pulmonary artery and right ventricular remodeling in rats with pulmonary artery hypertension by modulating cytokines expression].
    Wang X; Wang Y; Rong S; Ma H
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):427-32. PubMed ID: 25200042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
    Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
    Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer of hepatocyte growth factor with prostacyclin synthase in severe pulmonary hypertension of rats.
    Ono M; Sawa Y; Fukushima N; Suhara H; Nakamura T; Yokoyama C; Tanabe T; Matsuda H
    Eur J Cardiothorac Surg; 2004 Dec; 26(6):1092-7. PubMed ID: 15541968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor improves right ventricular remodeling in pulmonary arterial hypertensive rats via decreasing neurohormonal activation and inhibiting apoptosis.
    Wang X; Wang Y; Rong S; Ma H; Ma Q; Zhao J
    Chin Med J (Engl); 2014; 127(10):1924-30. PubMed ID: 24824257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tanshinone IIA sulfonate upregulated pulmonary artery smooth muscle peroxisome proliferator-activated receptor γ expression in monocrotaline induced pulmonary hypertension rat].
    Jiang Q; Chen Y; Chen X; Zhang J; Lu W; Wang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 May; 37(5):360-4. PubMed ID: 25011512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive and remedial application of etanercept attenuate monocrotaline-induced pulmonary arterial hypertension.
    Zhang LL; Lu J; Li MT; Wang Q; Zeng XF
    Int J Rheum Dis; 2016 Feb; 19(2):192-8. PubMed ID: 24612527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fasudil reverses monocrotaline-induced pulmonary hypertension in rats].
    Jiang H; Guan RJ; Wang HY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):239-44. PubMed ID: 23879951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
    Lee JH; Park BK; Oh KS; Yi KY; Lim CJ; Seo HW; Lee BH
    Int Immunopharmacol; 2016 Nov; 40():196-202. PubMed ID: 27611861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose-derived stem cells attenuate pulmonary arterial hypertension and ameliorate pulmonary arterial remodeling in monocrotaline-induced pulmonary hypertensive rats.
    Luo L; Lin T; Zheng S; Xie Z; Chen M; Lian G; Xu C; Wang H; Xie L
    Clin Exp Hypertens; 2015; 37(3):241-8. PubMed ID: 25271670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation.
    Zhai C; Shi W; Feng W; Zhu Y; Wang J; Li S; Yan X; Wang Q; Zhang Q; Chai L; Li C; Liu P; Li M
    Life Sci; 2018 Sep; 208():87-95. PubMed ID: 30009823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats.
    Lin Z; Jiang Z; Huang X; Cai X; Wang H; Xie L
    Clin Exp Hypertens; 2017; 39(6):495-501. PubMed ID: 28628347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
    Mei Y; Jin H; Tian W; Wang H; Wang H; Zhao Y; Zhang Z; Meng F
    Pulm Pharmacol Ther; 2011 Aug; 24(4):386-93. PubMed ID: 21396478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effects of PCPA against monocrotaline-induced pulmonary arterial hypertension are mediated through the downregulation of NFAT-1 and NF-κB.
    Bai Y; Li ZX; Wang HL; Lian GC; Wang Y
    Int J Mol Med; 2017 Jul; 40(1):155-163. PubMed ID: 28560440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrrolidine dithiocarbamate attenuates the development of monocrotaline-induced pulmonary arterial hypertension.
    Yavuz T; Uzun O; Macit A; Comunoglu C; Yavuz O; Silan C; Yuksel H; Yildirim HA
    Pathol Res Pract; 2013 May; 209(5):302-8. PubMed ID: 23582365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of baicalin on monocrotaline-induced pulmonary arterial hypertension by inhibiting inflammatory response.
    Luan Y; Chao S; Ju ZY; Wang J; Xue X; Qi TG; Cheng GH; Kong F
    Int Immunopharmacol; 2015 May; 26(1):188-93. PubMed ID: 25601497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor improves the survival of rats with pulmonary arterial hypertension via the amelioration of pulmonary hemodynamics.
    Hiramine K; Sata N; Ido A; Kamimura R; Setoyama K; Arai K; Nuruki N; Tanaka Y; Uto H; Tsubouchi H
    Int J Mol Med; 2011 Apr; 27(4):497-502. PubMed ID: 21318217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.